Mudita Advisors’s MaxCyte MXCT Stock Holding History

Mudita Advisors’s Portfolio MXCT Stock Details MXCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.37M	Hold	3,370,689	–	–	0.48%	26
2025 Q4	$5.22M	Hold	3,370,689	–	–	1.13%	18
2025 Q3	$5.33M	Hold	3,370,689	–	–	1.54%	14
2025 Q2	$7.35M	Buy	3,370,689 +42,248	+1%	+$102K	2.46%	14
2025 Q1	$9.09M	Buy	3,328,441 +105,034	+3%	+$414K	4.59%	9
2024 Q4	$13.4M	Buy	3,223,407 +69,966	+2%	+$264K	7.53%	5
2024 Q3	$12.3M	Buy	3,153,441 +167,101	+6%	+$704K	6.71%	6
2024 Q2	$11.7M	Buy	2,986,340 +710,959	+31%	+$3.06M	5.99%	7
2024 Q1	$9.53M	Buy	2,275,381 +394,032	+21%	+$1.85M	5.68%	6
2023 Q4	$8.84M	Buy	1,881,349 +490,491	+35%	+$1.91M	6.14%	7
2023 Q3	$4.34M	Buy	1,390,858 +561,200	+68%	+$2.26M	3.17%	10
2023 Q2	$3.81M	Buy	829,658 +167,005	+25%	+$767K	2.91%	14
2023 Q1	$3.28M	Buy	662,653 +572,452	+635%	+$2.82M	2.94%	11
2022 Q4	$492K	Buy	90,201 +28,967	+47%	+$178K	0.43%	18
2022 Q3	$398K	Buy	+61,234	New	+$342K	0.37%	19

Other funds holding MXCT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CFM

Capricorn Fund Managers London, United Kingdom $641M AUM 61.79% 1-Year Est. Return

Vitruvian Partners London, United Kingdom $112M AUM 2.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BFM

Brooklands Fund Management London, United Kingdom $88.9M AUM

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Mudita Advisors's MXCT Position: Q1 2026 in Review

Mudita Advisors held its MaxCyte (MXCT) position steady in Q1 2026 at 3,370,689 shares worth $2.37M. The position accounts for 0.48% of the portfolio, ranked #26.

Mudita Advisors first reported a position in MXCT in Q3 2022 and has held it in 15 quarters since. The position peaked at $13.4M in Q4 2024. 130 funds tracked by Wall St. Rank hold MXCT as of Q1 2026.

Mudita Advisors held 3,370,689 shares of MaxCyte worth $2.37M as of Q1 2026.
Mudita Advisors left its MaxCyte share count unchanged in Q1 2026.
MaxCyte made up 0.48% of Mudita Advisors's portfolio in Q1 2026, its #26 holding.
Mudita Advisors first reported a position in MaxCyte in Q3 2022 and has held it in 15 quarters since.
Mudita Advisors's MaxCyte position peaked at $13.4M in Q4 2024.
130 funds tracked by Wall St. Rank held MaxCyte as of Q1 2026.

Based on Mudita Advisors's 13F filing for Q1 2026, filed 14 May 2026.